Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.

LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS.

Vaccine. 2006 Jun 12;24(24):5220-34. Epub 2006 Apr 18.

PMID:
16650512
2.
3.

Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.

Guo L, Wang J, Zhou H, Si H, Wang M, Song J, Han B, Shu Y, Ren L, Qu J, Hung T.

Vaccine. 2008 Jan 24;26(4):460-8. Epub 2007 Dec 4.

PMID:
18160189
4.

Genetic and antigenic diversity among noroviruses.

Hansman GS, Natori K, Shirato-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Uchida K, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N.

J Gen Virol. 2006 Apr;87(Pt 4):909-19.

PMID:
16528040
7.

Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.

Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS.

J Virol. 2014 Jul;88(13):7256-66. doi: 10.1128/JVI.00785-14. Epub 2014 Apr 16.

8.

Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.

Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, Richardson C, Goodwin RR, Baehner F, Mendelman PM, Bargatze RF, Baric RS.

PLoS Med. 2015 Mar 24;12(3):e1001807. doi: 10.1371/journal.pmed.1001807. eCollection 2015 Mar.

9.

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Malm M, Tamminen K, Lappalainen S, Uusi-Kerttula H, Vesikari T, Blazevic V.

Clin Vaccine Immunol. 2015 Jun;22(6):656-63. doi: 10.1128/CVI.00015-15. Epub 2015 Apr 22.

10.

A recombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice.

Guo L, Zhou H, Wang M, Song J, Han B, Shu Y, Ren L, Si H, Qu J, Zhao Z, Wang J, Hung T.

Vaccine. 2009 Aug 20;27(38):5233-8. doi: 10.1016/j.vaccine.2009.06.065. Epub 2009 Jul 7.

PMID:
19589399
11.

Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses.

Jiang X, Zhong WM, Farkas T, Huang PW, Wilton N, Barrett E, Fulton D, Morrow R, Matson DO.

Arch Virol. 2002;147(1):119-30.

PMID:
11855626
12.

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.

Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T.

Vaccine. 2011 Oct 19;29(45):8126-33. doi: 10.1016/j.vaccine.2011.08.026. Epub 2011 Aug 18.

PMID:
21854823
13.

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS.

J Virol. 2009 Apr;83(7):3212-27. doi: 10.1128/JVI.01650-08. Epub 2009 Jan 28.

14.

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY.

Vaccine. 2012 May 21;30(24):3580-6. doi: 10.1016/j.vaccine.2012.03.050. Epub 2012 Mar 31.

15.

A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.

Wang X, Ku Z, Dai W, Chen T, Ye X, Zhang C, Zhang Y, Liu Q, Jin X, Huang Z.

Vaccine. 2015 Oct 26;33(43):5779-85. doi: 10.1016/j.vaccine.2015.09.043. Epub 2015 Sep 28.

PMID:
26424606
16.

Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice.

Kim SH, Chen S, Jiang X, Green KY, Samal SK.

J Virol. 2014 Sep 1;88(17):9718-27. doi: 10.1128/JVI.01570-14. Epub 2014 Jun 11.

17.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
19.

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.

Jiang B, Estes MK, Barone C, Barniak V, O'Neal CM, Ottaiano A, Madore HP, Conner ME.

Vaccine. 1999 Feb 26;17(7-8):1005-13.

PMID:
10067709
20.

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS.

J Virol. 2010 Feb;84(4):1800-15. doi: 10.1128/JVI.02179-09. Epub 2009 Dec 9.

Supplemental Content

Support Center